1-12 of 12
Branimir Jaksic
Close
Sort by
Journal Articles

Bcl-2 Family (Bcl-2, Mcl-1, Bim and Bax) and Btk Expression in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Lymphocytes in Different Lymphoid Compartments and Changes during Btk Inhibitor Therapies (ibrutinib or acalabrutinib)

Ozren Jaksic, Marija Ivic, Branimir Gizdic, Zdravko Mitrovic, Ena Soric, Ozana Jaksic, Anamarija Vrkljan Vuk, Mario Pirsic, Vlatko Pejsa, Branimir Jaksic, Rajko Kusec
Journal: Blood
Blood (2022) 140 (Supplement 1): 7002–7003.
https://doi.org/10.1182/blood-2022-169649
Published: 2022
Journal Articles

Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting

Ozren Jaksic, MDPhD, Marija Ivic, MD, Rajko Kusec, MD PhD, Zdravko Mitrovic, MD PhD, Mario Pirsic, MD, Branimir Jaksic, MD PhD, David Cicic, MD, Vlatko Pejsa, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-143030
Published: 2020
Journal Articles

Different Pattern of Expression of CD52, CD20 and CXCR-4 in Peripheral Blood, Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia (B-CLL),

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3877.
https://doi.org/10.1182/blood.V118.21.3877.3877
Published: 2011
Journal Articles

Different Pattern of CD154 and CD40 Expression On B-CLL and T Lymphocytes In Peripheral Blood, Bone Marrow and Lymph Node Microenvironment In B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Ozren Jaksic, MD, PhD, Branimir Gizdic, Tajana Stoos Veic, MD, Vlatka Pandzic Jaksic, MD, PhD, Rajko Kusec, MD, PhD, Vlatko Pejsa, MD, PhD, Branimir Jaksic, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3607.
https://doi.org/10.1182/blood.V116.21.3607.3607
Published: 2010
Journal Articles

Post-Thaw Viability of Cryopreserved Hematopoietic Progenitor Cell Grafts Influences Patients' Predisposition towards Infectious Complications in the Post-Transplant Period.

Radovan Vrhovac, Zinaida Peric, Silvana Jurenec, Ika Kardum-Skelin, Biljana Jelic-Puskaric, Zoran Siftar, Jasna Mesaric, Hrvoje Minigo, Branimir Jaksic
Journal: Blood
Blood (2009) 114 (22): 4666.
https://doi.org/10.1182/blood.V114.22.4666.4666
Published: 2009
Journal Articles

Febrile Neutropenia Following Autologous Stem Cell Transplantation in Patients with Lymphoma

Radovan Vrhovac, Zinaida Peric, Matko Kalac, Alen Ostojic, Visnja Kovacevic, Suzana Bukovski-Simonoski, Arjana Tambic-Andrasevic, Hrvoje Minigo, Branimir Jaksic
Journal: Blood
Blood (2008) 112 (11): 4379.
https://doi.org/10.1182/blood.V112.11.4379.4379
Published: 2008
Journal Articles

Alemtuzumab (CAMPATH®, MABCAMPATH®) Has Superior Progression Free Survival (PFS) vs Chlorambucil as Front-Line Therapy for Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (BCLL).

Peter Hillmen, Aleksander Skotnicki, Tadeusz Robak, Branimir Jaksic, Cynthia Sirard, Jiri Mayer
Journal: Blood
Blood (2006) 108 (11): 301.
https://doi.org/10.1182/blood.V108.11.301.301
Published: 2006
Journal Articles

More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)

Rajko Kusec, Ozren Jaksic, Slobodanka Ostojic, Ika Kardum-Skelin, Radovan Vrhovac, Branimir Jaksic
Journal: Blood
Blood (2006) 108 (1): 405–406.
https://doi.org/10.1182/blood-2005-12-5128
Published: 2006
Journal Articles

Differences between Peripheral Blood, Lymph Nodes and Bone Marrow in Expression of Integrins, ICAMs, CD38 and CD31 Correlate with Clinical Characteristics in B-CLL.

Branimir Jaksic, MD, PhD, Ozren Jaksic, MD, MSc, Mirjana M. Kardum-Paro, MSc, Ika Kardum-Skelin, MD, MSc
Journal: Blood
Blood (2005) 106 (11): 4981.
https://doi.org/10.1182/blood.V106.11.4981.4981
Published: 2005
Journal Articles

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Boris Labar, MD, PhD, Stefan Suciu, PhD, Petra Muus, MD, Roelof Willemze, MD, PhD, Jean-Pierre Marie, MD, Georges Fillet, MD, Zwi Berneman, MD, Branimir Jaksic, MDPhD, Walter Feremans, MD, Dominique Bron, MD, Henry Sinnige, MD, Martin Mistrik, MD, G. Vreugdenhil, MD, Robrecht De Bock, MD, Damir Nemet, MD, Caroline Gilotay, Theo de Witte, MDPhD, Sergio Amadori, MD
Journal: Blood
Blood (2005) 106 (11): 1834.
https://doi.org/10.1182/blood.V106.11.1834.1834
Published: 2005
Journal Articles

Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.

Peter Hillmen, MB ChB, PhD, Aleksander B. Skotnicki, MD, PhD, Tadeusz Robak, MD, PhD, Jiri Mayer, MD, PhD, Branimir Jaksic, MD, PhD, Vojo Vukovic, MD, PhD, Steven Weitman, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2505.
https://doi.org/10.1182/blood.V104.11.2505.2505
Published: 2004
Journal Articles

CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow

Ozren Jaksic, Mirjana Mariana Kardum Paro, Ika Kardum Skelin, Rajko Kusec, Vlatko Pejsa, Branimir Jaksic
Journal: Blood
Blood (2004) 103 (5): 1968–1969.
https://doi.org/10.1182/blood-2003-11-3890
Published: 2004